Analysis of Beta-Blockers Using UPLC with Accurate-Mass Screening

The World Anti-Doping Agency (WADA) includes beta-blockers in its 2014 Prohibited List (Category P2). Recent advances in liquid chromatography and mass spectrometry can help determine the presence of beta-blockers in urine. The Waters Forensic Toxicology Application Solution with UNIFI® enables analysts to confidently screen and identify beta-blocker drugs in urine; data is processed automatically and presented to the user with fully customizable workflows and reports.